Best Fulcrum Therapeutics SCD Alternatives for Android
-
Medable TeleVisit
0 Reviews
This app will be used to virtually connect sites and subjects via TeleVisit -
AEON 20002 EXT
0 Reviews
Aeon ABP-20002 Study Participant App. -
LOUiSSe
0 Reviews
A study app for subjects participating in the LOUiSSe Novartis clinical trial. -
AZ PETRA (D9720C00001)
0 Reviews
Designed for patients participating in research protocol D9720C00001(PETRA) -
CA116-001
0 Reviews
BMS CA116-001 Study Participant App -
DESTINY-PanTumor01
0 Reviews
This app is for participants in the DESTINY-PanTumor01 study. -
Merz Therapeutics PaiNT
0 Reviews
You are invited to participate in the Merz Therapeutics PaiNT study. -
5051-201: Patient
0 Reviews
Solely intended for study participants in the Sarepta - 5051-201 study. -
P23-899 Patient
0 Reviews
App for P23-899 Patients -
DESTINY-Breast07
0 Reviews
This app is for participants in the DESTINY-Breast07 study. -
CHONQUER
0 Reviews
This app is specifically intended for participants in the CHONQUER study only. -
Option VMS
0 Reviews
Option VMS study participant app -
J2P-MC-LXBD
0 Reviews
Phase 2b study of Diabetic Peripheral Neuropathic Pain -
AZ Monette
0 Reviews
Designed for patients participating in research protocol d533ac00001 (Monette) -
HYPERION ePRO (FR)
0 Reviews
This app is intended for study participants in the Acceleron A011-13-FR study -
CA116-003
0 Reviews
Application for participants in Bristol Myers Squibb CA116-003 study. -
CA209-6L6
0 Reviews
This app is specifically intended for BMS CA209-6L6 study only. -
SOTERIA eDiary
0 Reviews
This app is intended for study participants in the Acceleron A011-12 study only -
SAAVY (270-701)
0 Reviews
This app is intended for study participants in the BioMarin 270-701 study -
DS7300-188
0 Reviews
You are invited to participate in the Daiichi Sankyo - DS7300-188 study.
By clicking the Pre-register button you're about to pre-register for upcoming apps on APKPure Mobile App Store. Pre-registering means that you will receive a notification on your device when the app is released.
